Glox Therapeutics Awarded Share of 3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance SyndicateGlox Therapeutics is developing precision antibiotics to address antimicrobial resistance in cystic fibrosis.